Lung Foundation Australia / Boehringer Ingelheim: COPD Research Fellowship 2018/19

Lung Foundation Australia supports research to improve the diagnosis and management of Chronic Obstructive Pulmonary Disease (COPD) in Australia. Specifically, the proposed research must be aimed at developing and/or delivering optimal care to people with COPD.

Relevant domains of research inquiry range from evaluation of population screening initiatives; interventions to improve diagnostic accuracy within primary care; through to issues of management in the context of a clinician-patient interaction to system level issues to do with the organisation, financing and performance of the health system, including COPD management of indigenous and ethnic minorities within Australia.

Funding & Duration

The Fellowship is available as either a one- or two-year award, with a value of AUD $80,000 per annum, and is tenable in conjunction with additional financial support.

The Fellowship will be awarded at the next Annual Scientific Meeting of the TSANZ and must be taken up within 12 months of receipt.


Applications are invited from medical and scientific graduates who will be resident in Australia throughout the period of the research program.

Applicants must be a financial member/associate member of The Australian Lung Foundation and the Thoracic Society of Australia & New Zealand.

Submission Requirements & Due Date

  • Applications must be submitted for internal review by 18 September 2017
  • Please email if you are considering applying for this scheme.

Further Information

Need Help?

This entry was posted in Fellowships & Scholarships, Funding by Award Type, Health & Medical Sciences. Bookmark the permalink.

Comments are closed.